Dr. Kevin Williams is the Chief Medical Officer (CMO) for Pfizer Rare Disease. In this role, he leads a Medical Affairs organization of approximately 150 medical colleagues around the globe supporting Pfizer’s efforts and portfolio in Rare Disease.
#NNPA BlackPress

Diving into the Genetics of Sickle Cell Disease

NNPA NEWSWIRE — Research indicates that as many as 3 million Americans carry the sickle cell trait, primarily impacting African Americans. In fact, nearly 1 in 12 African Americans have the sickle cell trait. […read more]

Advertisements
Musician Bone Davis
Community

HEALTH MATTERS: Bone Davis brings global awareness to sickle cell disease

WAVE NEWSPAPERS — He made a name for himself as a keyboardist, playing rhythm and blues and jazz with a diverse group of music legends including B.B. King, Chick Corea, Les McCann, Con Funk Shun, Nancy Wilson, the Blasters, Poison, Wild Cherry and the Wu-Tang Clan, to name a few. Both of Davis’ parents had the trait. Davis was diagnosed with sickle cell anemia at birth. […read more]

Dr. Kevin Williams is the Chief Medical Officer (CMO) for Pfizer Rare Disease. In this role, he leads a Medical Affairs organization of approximately 150 medical colleagues around the globe supporting Pfizer’s efforts and portfolio in Rare Disease.
Commentary

ASK DR. KEVIN: Shedding Light on the “Invisible Symptoms” of Sickle Cell Disease

NNPA NEWSWIRE — What I’ve heard time and time again from people living with Sickle Cell Disease (SCD) is that they often feel isolated in their journey. Kyle, a patient living with SCD, recently summed it up nicely when he said, “Sometimes it is hard to just get out of bed. What it means to live in pain is not something that many can truly understand.” […read more]

The Cure Sickle Cell Initiative seeks to develop cures for a far broader group of individuals with the disease, and it is initially focusing on gene therapies that modify the patient’s own hematopoietic stem cells (HSCs), which make red and other blood cells.
Featured

NIH launches initiative to accelerate genetic therapies to cure sickle cell disease

“This initiative is giving patients, families, and communities a reason for hope. I’m particularly pleased that we are able to make this announcement during Sickle Cell Awareness month, when we are shining a spotlight on the toll of this devastating disease,” — ADM Brett Giroir, M.D. Asst. Sec. for Health, U.S. Dept. of Health & Human Services (HHS) […read more]

Black History

PRESS ROOM: Pfizer and the National Newspaper Publishers Association Collaborate to Raise Awareness of Sickle Cell Disease and Need for Improved Patient Care

Media Contacts: Steven Danehy 212-733-1538 Steven.Danehy@pfizer.com Claudette Perry 212-588-8764 Ext. 2 cperry@nnpa.org Collaboration Aims to Educate on the Importance of Clinical Trials in Developing Potential New Sickle Cell Disease Therapies NEW YORK, NY, March 24, 2017 – Pfizer Inc. (NYSE:PFE) and the National Newspaper Publishers Read More